VivoSeq
Other

Methylprednisolone

0

Pipeline Programs↗

5

Active Trials↗

4

Companies Involved↗

Methylprednisolone is an early-stage landscape with 0 programs across 4 companies. The most active players are Pfizer, Oncotherapeutics, Biogen.

Intelligence

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

79/100

Attrition Rate

14/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Pfizer logo

Pfizer

0 programs

PreclinicalO

Oncotherapeutics

0 programs

PreclinicalBiogen logo

Biogen

0 programs

PreclinicalVertex Pharmaceuticals logo

Vertex Pharmaceuticals

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

57

clinical trials

Completed30 · 53%
Unknown status14 · 25%
Withdrawn4 · 7%
Terminated4 · 7%
Recruiting3 · 5%
Active, not recruiting1 · 2%
Other1 · 2%

Clinical Trials

Trial Activity

57 trials

A Trial of Selinexor, Ruxolitinib and Methylprednisolone
Recruiting·OOncotherapeutics·Phase 1·NCT06225310·30 enrolled
Efficacy of Methylprednisolone for Pain Control After ACL Repair
Recruiting·SSt. Louis University·Phase 4·NCT07158476·90 enrolled
Comparison of Submucosal Dexamethasone and Methylprednisolone in Postoperative Sequelae of Parasymphsis Fractures
Recruiting·NNishtar Medical University·Phase 2·NCT07208799·72 enrolled
Rituximab + High-Dose Methylprednisolone Debulking Prior to Venetoclax for CLL & SLL Patients
Active, not recruiting·UUniversity of California, San Diego·Phase 1·NCT04981912·4 enrolled
A Randomized Clinical Trial of Intravenous Methylprednisolone With 2 Protocols in Patients With Graves Orbitopathy
Not yet recruiting·TThird Affiliated Hospital, Sun Yat-Sen University·Phase 4·NCT06510114·150 enrolled
Impact of Intravenous Methylprednisolone Treatment on Blood Pressure
Completed·MMedical University of Warsaw·N/A·NCT03590080·32 enrolled
Effect of Methylprednisolone on Immune Signaling in Hip-arthroplasty Patients
Completed·—·Phase 2/3·NCT02542592·64 enrolled
Urinary Aquaporin 2 Excretion After Methylprednisolone in Fasting Healthy Humans
Completed·RRegional Hospital Holstebro·Phase 4·NCT00281710·20 enrolled
Avonex (Interferon-beta-1a) and Avonex Plus Methylprednisolone for the Treatment of Relapsing-remitting MS
Completed·Biogen logoBiogen·Phase 4·NCT00168766·345 enrolled
A Study Comparing Drug Availability Of Methylprednisolone In Liquid Form Versus Methylprednisolone In Tablet Form
Completed·Pfizer logoPfizer·Phase 1·NCT01267201·24 enrolled
The Effect of Methylprednisolone on the Reversal Time of Rocuronium by Sugammadex in the Pediatric Patient Group
Completed·KKonya City Hospital·Phase 4·NCT06623370·80 enrolled
A Randomized Study of IVIG vs. IVIG With High Dose Methylprednisolone in Childhood ITP.
Completed·TThe Hospital for Sick Children·Phase 3·NCT00376077·32 enrolled
Effect of Methylprednisolone on Complement Activation in Patients Undergoing Total Knee-arthroplasty
Completed·—·Phase 3·NCT02332616·70 enrolled
Phase 1 PK Interaction Study Between VX-509 and Prednisone or Methylprednisolone in Healthy Male Subjects
Completed·Vertex Pharmaceuticals logoVertex Pharmaceuticals·Phase 1·NCT01886209·28 enrolled
Comparison of Efficacy of Dexamethasone and Methylprednisolone in Moderate to Severe Covid 19 Disease
Completed·FFatima Memorial Hospital·Phase 3·NCT04603729·100 enrolled
Page 1 of 4

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)